Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are two of the key subgroups of pulmonary hypertension. They are characterised by different risk factors. PAH can be associated with mutations in the gene encoding bone morphogenetic protein receptor type...
Main Author: | M. Humbert |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2010-03-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/cgi/content/full/19/115/59 |
Similar Items
-
Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension
by: Hidetoshi Chibana, et al.
Published: (2017-12-01) -
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Z S Valieva, et al.
Published: (2016-03-01) -
Giant Pulmonary Artery Thrombotic Material, Due to Chronic Thromboembolic Pulmonary Hypertension, Mimics Pulmonary Artery Sarcoma
by: Helen Triantafyllidi, et al.
Published: (2021-09-01) -
Incidence of chronic thromboembolic pulmonary hypertension in Thammasat University Hospital
by: Suphathat Puengpapat, et al.
Published: (2018-01-01) -
Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
by: Thomas Koudstaal, et al.
Published: (2020-02-01)